LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 417

Search options

  1. Article ; Online: Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations.

    Shah, Bhumi M / Sagar, Sneha R / Trivedi, Priti

    Journal of biomolecular structure & dynamics

    2021  Volume 40, Issue 24, Page(s) 13778–13798

    Abstract: Diabetes is one of the leading causes of death globally as per World Health Organization 2019. To cope up with side effects of current diabetes therapy, researchers have found several novel targets for the treatment of diabetes. Currently, dipeptidyl ... ...

    Abstract Diabetes is one of the leading causes of death globally as per World Health Organization 2019. To cope up with side effects of current diabetes therapy, researchers have found several novel targets for the treatment of diabetes. Currently, dipeptidyl peptidase IV (DPP IV) has emerged as a target in modulating the diabetes physiology. In the present work, various 3D-Quantitative structure activity relationship (QSAR) techniques namely comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis, topomer CoMFA and molecular hologram QSAR are used to explore the structural requirements of triazole derivatives as DPP IV inhibitors. Different models generated by 3D QSAR studies had acceptable statistical values for further prediction of molecules. From the contour maps of QSAR results, important structural features are deduced. Substitutions on N
    MeSH term(s) Humans ; Models, Molecular ; Dipeptidyl-Peptidase IV Inhibitors/pharmacology ; Dipeptidyl-Peptidase IV Inhibitors/chemistry ; Quantitative Structure-Activity Relationship ; Triazoles/pharmacology ; Triazoles/chemistry ; Diabetes Mellitus ; Molecular Docking Simulation
    Chemical Substances Dipeptidyl-Peptidase IV Inhibitors ; Triazoles
    Language English
    Publishing date 2021-11-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 49157-3
    ISSN 1538-0254 ; 0739-1102
    ISSN (online) 1538-0254
    ISSN 0739-1102
    DOI 10.1080/07391102.2021.1994876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.

    Shah, Bhumi / Modi, Palmi / Sagar, Sneha R

    Life sciences

    2020  Volume 252, Page(s) 117652

    Abstract: Aims: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high ...

    Abstract Aims: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high contagious nature. Precautionary measures remain the sole obliging tactic to cease the person to person transmissions till any effective method of treatment or vaccine is developed. Amidst the pandemic, research and development of new molecule is labour-intensive and tedious process. Drug repurposing is the concept of identifying therapeutically potent molecule from the library of pre-existing molecules.
    Materials and methods: In the present study, 61 molecules that are already being used in clinics or under clinical scrutiny as antiviral agents are surveyed via docking study. Docking study was performed using Maestro interface (Schrödinger Suite, LLC, NY).
    Key findings: Out of these 61 molecules, 37 molecules were found to interact with >2 protein structures of COVID-19. The docking results indicate that amongst the reported molecules, HIV protease inhibitors and RNA-dependent RNA polymerase inhibitors showed promising features of binding to COVID-19 enzyme. Along with these, Methisazone an inhibitor of protein synthesis, CGP42112A an angiotensin AT2 receptor agonist and ABT450 an inhibitor of the non-structural protein 3-4A might become convenient treatment option as well against COVID-19.
    Significance: The drug repurposing approach provide an insight about the therapeutics that might be helpful in treating corona virus disease.
    MeSH term(s) Antiviral Agents/chemistry ; Betacoronavirus/enzymology ; COVID-19 ; Computer Simulation ; Coronavirus 3C Proteases ; Coronavirus Infections/drug therapy ; Coronavirus Infections/virology ; Cysteine Endopeptidases/chemistry ; Drug Repositioning ; Molecular Docking Simulation ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/chemistry
    Chemical Substances Antiviral Agents ; Viral Nonstructural Proteins ; Cysteine Endopeptidases (EC 3.4.22.-) ; Coronavirus 3C Proteases (EC 3.4.22.28)
    Keywords covid19
    Language English
    Publishing date 2020-04-09
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2020.117652
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: In silico studies on therapeutic agents for COVID-19

    Shah, Bhumi / Modi, Palmi / Sagar, Sneha R.

    Life Sciences

    Drug repurposing approach

    2020  Volume 252, Page(s) 117652

    Keywords General Pharmacology, Toxicology and Pharmaceutics ; General Biochemistry, Genetics and Molecular Biology ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2020.117652
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Finding Needles in the Haystack: Strategies for Uncovering Noncoding Regulatory Variants.

    Chen, You / Paramo, Mauricio I / Zhang, Yingying / Yao, Li / Shah, Sagar R / Jin, Yiyang / Zhang, Junke / Pan, Xiuqi / Yu, Haiyuan

    Annual review of genetics

    2023  Volume 57, Page(s) 201–222

    Abstract: Despite accumulating evidence implicating noncoding variants in human diseases, unraveling their functionality remains a significant challenge. Systematic annotations of the regulatory landscape and the growth of sequence variant data sets have fueled ... ...

    Abstract Despite accumulating evidence implicating noncoding variants in human diseases, unraveling their functionality remains a significant challenge. Systematic annotations of the regulatory landscape and the growth of sequence variant data sets have fueled the development of tools and methods to identify causal noncoding variants and evaluate their regulatory effects. Here, we review the latest advances in the field and discuss potential future research avenues to gain a more in-depth understanding of noncoding regulatory variants.
    MeSH term(s) Humans ; Genetic Predisposition to Disease ; Genetic Variation/genetics ; Genome-Wide Association Study/methods ; Polymorphism, Single Nucleotide/genetics
    Language English
    Publishing date 2023-08-10
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 207928-8
    ISSN 1545-2948 ; 0066-4170 ; 0066-4197
    ISSN (online) 1545-2948
    ISSN 0066-4170 ; 0066-4197
    DOI 10.1146/annurev-genet-030723-120717
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Bruchs Membrane Opening Area Measurement in Healthy Nepalese Eyes.

    Kharel Sitaula, Ranju / Shah, Ganga Sagar

    Journal of Nepal Health Research Council

    2024  Volume 21, Issue 4, Page(s) 599–602

    Abstract: Background: Bruch's membrane opening area is the circular area around the disc of Bruch's membrane, which is devoid of Bruch's membrane and can be assessed by capturing the retinal imaging system by Spectral-domain optical coherence tomography. BMOA can ...

    Abstract Background: Bruch's membrane opening area is the circular area around the disc of Bruch's membrane, which is devoid of Bruch's membrane and can be assessed by capturing the retinal imaging system by Spectral-domain optical coherence tomography. BMOA can be a new landmark in analyzing the glaucomatous optic nerve head, myopic optic disc, optic neuropathy and uveitic disc edema. This is the first study from South Asia to evaluate the normal Bruch's membrane opening area among Nepalese eyes.
    Methods: This hospital-based, cross-sectional, quantitative, observational study cross-sectional study was conducted in a tertiary eye care hospital in Nepal. Healthy immunocompetent Nepalese participants of both genders and different age groups were enrolled. The mean average Bruch's membrane opening area of each eyes, the difference in Bruch's membrane opening area between the two eyes and the gender of varying age groups were analyzed.
    Results: Around 162 eyes (81 participants) were analyzed. The mean age was 56.69±17.5years. The mean average Bruch's membrane opening area of the right and left eye was 2.53±0.58 mm2 and 2.50 ±0.58 mm2. There was no significant difference in the Bruch's membrane opening area in either eye in both genders of any age group.
    Conclusion: The Bruch's membrane opening area does not differ significantly according to the laterality, gender and age group in Nepalese eyes.
    MeSH term(s) Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Bruch Membrane/diagnostic imaging ; Cross-Sectional Studies ; Functional Laterality ; Nepal ; South Asian People
    Language English
    Publishing date 2024-03-31
    Publishing country Nepal
    Document type Observational Study ; Journal Article
    ZDB-ID 2551251-1
    ISSN 1999-6217 ; 1999-6217
    ISSN (online) 1999-6217
    ISSN 1999-6217
    DOI 10.33314/jnhrc.v21i4.4839
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Impact of Underlying Congestive Heart Failure on In-Hospital Outcomes in Patients with Septic Shock.

    Vindhyal, Mohinder R / Lu, Liuqiang Kelsey / Ranka, Sagar / Acharya, Prakash / Shah, Zubair / Gupta, Kamal

    Journal of intensive care medicine

    2021  Volume 37, Issue 7, Page(s) 965–969

    Abstract: Purpose: ...

    Abstract Purpose:
    MeSH term(s) Cross-Sectional Studies ; Heart Failure/complications ; Hospitals ; Humans ; Retrospective Studies ; Shock, Septic/complications
    Language English
    Publishing date 2021-11-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 632828-3
    ISSN 1525-1489 ; 0885-0666
    ISSN (online) 1525-1489
    ISSN 0885-0666
    DOI 10.1177/08850666211061472
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Post-traumatic suprachoroidal dislocation of crystalline lens and its management.

    Shanmugam, Mahesh P / Shah, Payal / Rajesh, R / Mishra, Divyansh K / Sagar, Pradeep / Sheemar, Abhishek

    Indian journal of ophthalmology

    2019  Volume 67, Issue 9, Page(s) 1469–1470

    MeSH term(s) Adult ; Eye Injuries/complications ; Eye Injuries/diagnosis ; Humans ; Lens Subluxation/diagnosis ; Lens Subluxation/etiology ; Lens Subluxation/surgery ; Lens, Crystalline/diagnostic imaging ; Lens, Crystalline/injuries ; Male ; Ultrasonography ; Vitrectomy/methods ; Vitreous Hemorrhage/diagnosis ; Vitreous Hemorrhage/etiology ; Vitreous Hemorrhage/surgery
    Language English
    Publishing date 2019-08-21
    Publishing country India
    Document type Case Reports ; Journal Article ; Video-Audio Media
    ZDB-ID 187392-1
    ISSN 1998-3689 ; 0301-4738
    ISSN (online) 1998-3689
    ISSN 0301-4738
    DOI 10.4103/ijo.IJO_1656_18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: In silico studies on therapeutic agents for COVID-19: Drug repurposing approach

    Shah, Bhumi / Modi, Palmi / Sagar, Sneha R

    Life Sci

    Abstract: AIMS: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high ... ...

    Abstract AIMS: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high contagious nature. Precautionary measures remain the sole obliging tactic to cease the person to person transmissions till any effective method of treatment or vaccine is developed. Amidst the pandemic, research and development of new molecule is labour-intensive and tedious process. Drug repurposing is the concept of identifying therapeutically potent molecule from the library of pre-existing molecules. MATERIALS AND METHODS: In the present study, 61 molecules that are already being used in clinics or under clinical scrutiny as antiviral agents are surveyed via docking study. Docking study was performed using Maestro interface (Schrödinger Suite, LLC, NY). KEY FINDINGS: Out of these 61 molecules, 37 molecules were found to interact with >2 protein structures of COVID-19. The docking results indicate that amongst the reported molecules, HIV protease inhibitors and RNA-dependent RNA polymerase inhibitors showed promising features of binding to COVID-19 enzyme. Along with these, Methisazone an inhibitor of protein synthesis, CGP42112A an angiotensin AT2 receptor agonist and ABT450 an inhibitor of the non-structural protein 3-4A might become convenient treatment option as well against COVID-19. SIGNIFICANCE: The drug repurposing approach provide an insight about the therapeutics that might be helpful in treating corona virus disease.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #46308
    Database COVID19

    Kategorien

  9. Article: In silico studies on therapeutic agents for COVID-19: Drug repurposing approach

    Shah, Bhumi / Modi, Palmi / Sagar, Sneha R

    Life sciences. 2020 July 01, v. 252

    2020  

    Abstract: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high ... ...

    Abstract The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high contagious nature. Precautionary measures remain the sole obliging tactic to cease the person to person transmissions till any effective method of treatment or vaccine is developed. Amidst the pandemic, research and development of new molecule is labour-intensive and tedious process. Drug repurposing is the concept of identifying therapeutically potent molecule from the library of pre-existing molecules.In the present study, 61 molecules that are already being used in clinics or under clinical scrutiny as antiviral agents are surveyed via docking study. Docking study was performed using Maestro interface (Schrödinger Suite, LLC, NY).Out of these 61 molecules, 37 molecules were found to interact with >2 protein structures of COVID-19. The docking results indicate that amongst the reported molecules, HIV protease inhibitors and RNA-dependent RNA polymerase inhibitors showed promising features of binding to COVID-19 enzyme. Along with these, Methisazone an inhibitor of protein synthesis, CGP42112A an angiotensin AT2 receptor agonist and ABT450 an inhibitor of the non-structural protein 3-4A might become convenient treatment option as well against COVID-19.The drug repurposing approach provide an insight about the therapeutics that might be helpful in treating corona virus disease.
    Keywords Coronavirus infections ; Human immunodeficiency virus ; RNA-directed RNA polymerase ; Severe acute respiratory syndrome coronavirus ; agonists ; antiviral agents ; computer simulation ; pandemic ; protein structure ; protein synthesis ; proteinase inhibitors ; research and development ; therapeutics ; vaccines ; viral nonstructural proteins ; viruses ; China ; covid19
    Language English
    Dates of publication 2020-0701
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2020.117652
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Advances in Brain Cancer: Creating Monoallelic Single Point Mutation in IDH1 by Single Base Editing.

    Shah, Sagar R / Quinones-Hinojosa, Alfredo / Xia, Shuli

    Journal of oncology research and therapy

    2018  Volume 5, Issue 5

    Abstract: Mutations in the Isocitrate Dehydrogenase 1 (IDH1) gene occur in 70% of grade II and grade III gliomas, 10% of acute myeloid leukemia, as well as cholangiocarcinomas, melanomas, and chondrosarcomas. Numerous mechanisms have been proposed to illustrate ... ...

    Abstract Mutations in the Isocitrate Dehydrogenase 1 (IDH1) gene occur in 70% of grade II and grade III gliomas, 10% of acute myeloid leukemia, as well as cholangiocarcinomas, melanomas, and chondrosarcomas. Numerous mechanisms have been proposed to illustrate the biological function of mutant IDH1. Most functional studies of mutant IDH1 have been conducted in exogenous overexpression systems with the IDH1 wild type background. This mini-review comments on recent publication by Wei et al, in which a highly efficient "single base editing" approach was employed to generate monoallelic IDH1 R132H mutation without the induction of a double strand break in the IDH1 gene.
    Language English
    Publishing date 2018-10-03
    Publishing country United States
    Document type Journal Article
    ISSN 2574-710X
    ISSN (online) 2574-710X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top